Latest News

New blood thinner cuts risk of further events
Written by: Schiller
Next generation of stress testing - with HyperQ
Women fail to get to hospital quickly during heart attacks
Avoiding risk factors boosts healthy heart years by 11-13 years
Written by: SCHILLER’s FRED easyport saved life of a young triathlete
SCHILLER’s FRED easyport saved life of a young triathlete
Written by: BIOTRONIK ProMRI Devices
ProMRI studies confirm safety of MR imaging with BIOTRONIK devices – results published in Heart Rhythm…
Written by: DuraGraft now available in Europe through key distributors
Somahlution announces new global distribution partnerships for Duragraft® vascular conduit solution
Written by: www.miracormedical.com
Miracor Medical Systems receives additional funding to accelerate clinical validation and commercialization…
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL™ …
Written by: www.firstwordmedtech.com
Philips to buy image-guided therapy company Volcano for $1.2 billion

External news

Written by: Cardiovascular Business
Implantable PA sensor for heart failure linked to positive 1-year outcomes
Written by: Cardiac Vascular News
Conformal Medical Announces Launch of the GLACE Study with Next-Gen CLAAS® AcuFORM™ Left Atrial Appendage Occlusion Device
Written by: Medscape
Time-Restricted Eating Is Not a Metabolic Magic Bullet
Written by: Medscape
Does Metformin Therapy Impact CVD in T2D? It's Complicated
Written by: heart.org - Stroke news
Nominate a stroke hero today: 2025 Stroke Hero Awards open for submissions
Written by: heart.org - Stroke news
Nomine hoy a un héroe del derrame cerebral: Ya está abierto el plazo de presentación de candidaturas para los Stroke Hero Awards 2025
Written by: Cardiac Vascular News
Remedy Pharmaceuticals’ Phase 3 Trial in Large Lesion Stroke Patients Demonstrates Statistically Significant Effect at One Year
Written by: Cardiac Vascular News
Synchron Announces Positive Results from U.S. COMMAND Study of Endovascular Brain-Computer Interface
Written by: Cardiac Vascular News
Pi-Cardia Receives FDA Market Clearance for ShortCut™
Written by: Cardiac Vascular News
Rivus Pharmaceuticals Announces New Clinical Data from Phase 2a HuMAIN Trial Demonstrating Significant Weight Loss with HU6 in Patients with Obesity-Related Heart Failure